Infection Control and Hospital Epidemiology Publication Info
For individual subscriptions, please contact the The University of Chicago Press
University of Chicago Press Customer Service:
1.877.705.1878 (toll-free, U.S. & Canada)
1.773.753.3347 (international)
subscriptions@press.uchicago.edu
For information about institutional access to this title, please visit the Institutional Subscriptions page.
Attributable Morbidity and Mortality of Catheter‐Related Septicemia in Critically Ill Patients: A Matched, Risk‐Adjusted, Cohort Study
Formats Available in JSTOR: PDF
Abstract(back to top)
OBJECTIVE. To determine the attributable risk of death due to catheter‐related septicemia (CRS) in critically ill patients when taking into account severity of illness during the intensivecare unit (ICU) stay but before CRS.
DESIGN. Pairwise‐matched (1:2) exposed‐unexposed study.
SETTING. 10‐bed medical‐surgical ICU and an 18‐bed medical ICU.
PATIENTS. Patients admitted to either ICU between January 1, 1990, and December 31, 1995, were eligible. Exposed patients were defined as patients with CRS; unexposed controls were selected according to matching variables.
METHODS. Matching variables were diagnosis at ICU admission, length of central catheterization before the infection, McCabe Score, Simplified Acute Physiologic Score (SAPS) II at admission, age, and gender. Severity scores (SAPS II, Organ System Failure Score, Organ Dysfunction and Infection Score, and Logistic Organ Dysfunction System) were calculated four times for each patient: the day of ICU admission, the day of CRS onset, and 3 and 7 days before CRS. Matching was successful for 38 exposed patients. Statistical analysis was based on nonparametric tests for epidemiological data and on Cox’s models for the exposed‐unexposed study, with adjustment on matching variables and prognostic factors of mortality.
RESULTS. CRS complicated 1.17 per 100 ICU admissions during the study period. Twenty (53%) of the CRS cases were associated with septic shock. CRS was associated with a 28% increase in SAPS II. Crude ICU mortality rates from exposed and unexposed patients were 50% and 21%, respectively. CRS remained associated with mortality even when adjusted on other prognostic factors at ICU admission (relative risk [RR], 2.01; 95% confidence interval [CI95], 1.08‐3.73; P=.03). However, after adjustment on severity scores calculated between ICU admission and 1 week before CRS, the increased mortality was no longer significant (RR, 1.41; CI95, 0.76‐2.61; P=.27).
CONCLUSION. CRS is associated with subsequent morbidity and mortality in the ICU, even when adjusted on severity factors at ICU admission. However, after adjustment on severity factors during the ICU stay and before the event, there was only a trend toward CRS‐attributable mortality. The evolution of patient severity should be taken into account when evaluating excess mortality induced by nosocomial events in ICU patients.
Bibliographic Information(back to top)
- Attributable Morbidity and Mortality of Catheter‐Related Septicemia in Critically Ill Patients: A Matched, Risk‐Adjusted, Cohort Study
- Lilia Soufir , MD, Jean‐François Timsit , MD, Cédric Mahe , MD, Jean Carlet , MD, Bernard Regnier , MD and Sylvie Chevret , MD, PhD
- Infection Control and Hospital Epidemiology
- Vol. 20, No. 6 (June 1999) (pp. 396-401)
Notes and References(back to top)
This item contains 1 note(s).
Notes
From the Clinique de réanimation des maladies infectieuses (Drs. Timsit and Regnier), Hôpital Universitaire Bichat Claude‐Bernard; Service de réanimation polyvalente (Drs. Soufir, Timsit, and Carlet), Hôpital Saint‐Joseph; Département de Biostatistique et Informatique Médicale (Drs. Mahe and Chevret), Hôpital Universitaire Saint‐Louis, Paris, France.Address reprint requests to J‐F Timsit, Réanimation polyvalente, Hôpital Saint Joseph, 185 rue Raymond Losserand, 75014 Paris, France.98‐OA‐135. Soufir L, Timsit J‐F, Mahe C, Carlet J, Regnier B, Chevret S. Attributable morbidity and mortality of catheter‐related septicemia in critically ill patients: a matched, risk‐adjusted, cohort study. Infect Control Hosp Epidemiol 1999;20:396‐401.
Items Citing this Item (back to top)
22 item(s) in JSTOR cite this item
- Christopher J. Crnich , MD, MSVol. 31, No. 11 (November 2010) pp. 1115-1117Stable URL: http://www.jstor.org/stable/10.1086/656594
- Jean‐Marie Januel , MPH, RN; Stephan Harbarth , MD, MS; Robert Allard , MD, MSc; Nicolas Voirin , MSc; Alain Lepape , MD; Bernard Allaouchiche , MD, PhD; Claude Guerin , MD, PhD; Jean‐Jacques Lehot , MD, PhD; Marc‐Olivier Robert , MD, PhD; Gérard Fournier , MD; Didier Jacques , MD; Dominique Chassard , MD, PhD; Pierre‐Yves Gueugniaud , MD, PhD; François Artru , MD; Paul Petit , MD; Dominique Robert , MD; Ismaël Mohammedi , MD; Raphaëlle Girard , MD; Jean‐Charles Cêtre , MD; Marie‐Christine Nicolle , MD; Jacqueline Grando , MD; Jacques Fabry , MD; Philippe Vanhems , MD, PhDVol. 31, No. 4 (April 2010) pp. 388-394Stable URL: http://www.jstor.org/stable/10.1086/650754
- Petra Gastmeier , MD; Karin Menzel , MD; Dorit Sohr , PhD; Henning Rüden , MDVol. 28, No. 4 (April 2007) pp. 453-458Stable URL: http://www.jstor.org/stable/10.1086/512630
- Mordechai Grupper , MD; Hanna Sprecher , PhD; Tania Mashiach , MA; Renato Finkelstein , MDVol. 28, No. 3 (March 2007) pp. 293-298Stable URL: http://www.jstor.org/stable/10.1086/512629
- Pascale Fabbro‐Peray , MD, PhD; A. Sotto , MD, PhD; C. Defez , MD; M. Cazaban , MD; L. Molinari , BSc; M. Pinède , BSc; A. Mahamat , MD; J.P. Daurès , MD, PhDVol. 28, No. 3 (March 2007) pp. 265-272Stable URL: http://www.jstor.org/stable/10.1086/512626
- Mazen S. Bader , MD, MPHVol. 27, No. 11 (November 2006) pp. 1219-1225Stable URL: http://www.jstor.org/stable/10.1086/507924
- Maite Garrouste-Orgeas, Jean François Timsit, Muriel Tafflet, Benoit Misset, Jean-Ralph Zahar, Lilia Soufir, Thierry Lazard, Samir Jamali, Bruno Mourvillier, Yves Cohen, Arnaud De Lassence, Elie Azoulay, Christine Cheval, Adrien Descorps-Declere, Christophe Adrie, Marie-Alliette Costa de Beauregard, Jean CarletVol. 42, No. 8 (Apr. 15, 2006) pp. 1118-1126Stable URL: http://www.jstor.org/stable/4463795
- Albert G. Crawford , PhD; Joseph P. Fuhr , Jr., PhD; Bhaskar Rao , MBAVol. 25, No. 8 (August 2004) pp. 668-674Stable URL: http://www.jstor.org/stable/10.1086/502459
- Olivier Lesens , MD; Cédric Methlin , MD; Yves Hansmann , MD; Véronique Remy , MD; Martin Martinot , MD; Colm Bergin , MD; Pierre Meyer; Daniel Christmann , MDVol. 24, No. 12 (December 2003) pp. 890-896Stable URL: http://www.jstor.org/stable/10.1086/502156
- Giovanni Battista Orsi , MD; Lidia Di Stefano , MD; Norman Noah , MB, FRCPVol. 23, No. 4 (April 2002) pp. 190-197Stable URL: http://www.jstor.org/stable/10.1086/502034
- Michael J. Richards , MBBS, FRACP; Jonathan R. Edwards , MS; David H. Culver , PhD; Robert P. Gaynes , MD; theVol. 21, No. 8 (August 2000) pp. 510-515Stable URL: http://www.jstor.org/stable/10.1086/501795
- Sanjay Saint , MD, MPH; David L. Veenstra , PhD, PharmD; Benjamin A. Lipsky , MDVol. 21, No. 6 (June 2000) pp. 375-380Stable URL: http://www.jstor.org/stable/10.1086/501776
- Barry M. Farr , MD, MSc; David E. Shapiro , PhDVol. 21, No. 4 (April 2000) pp. 278-284Stable URL: http://www.jstor.org/stable/10.1086/501760
- J. H. Wagenvoort; H. M. Toenbreker; T. J. Werink; H. H. BerendsenVol. 21, No. 4 (April 2000) pp. 251-252Stable URL: http://www.jstor.org/stable/10.1086/503220
- E. A. Bryce; K. Dorovoni‐Zis; D. Trudeau; M. Sinclair; F. J. RobertsVol. 21, No. 4 (April 2000) pp. 247-248Stable URL: http://www.jstor.org/stable/10.1086/503215
- C. C. Cardoso; J. E. Fiorini; L. R. Ferriera; J. W. Gurjao; L. A. AmaralVol. 21, No. 4 (April 2000) p. 248Stable URL: http://www.jstor.org/stable/10.1086/503216
- C. Webster; K. J. Towner; H. HumphreysVol. 21, No. 4 (April 2000) p. 246Stable URL: http://www.jstor.org/stable/10.1086/503214
- R. O. Suara; M. Young; I. ReevesVol. 21, No. 4 (April 2000) pp. 250-251Stable URL: http://www.jstor.org/stable/10.1086/503219
- A. E. MaciasVol. 21, No. 4 (April 2000) pp. 248-249Stable URL: http://www.jstor.org/stable/10.1086/503217
- C. WallsVol. 21, No. 4 (April 2000) pp. 249-250Stable URL: http://www.jstor.org/stable/10.1086/503218
- Jérôme Robert , MD, MPH; Scott K. Fridkin , MD; Henry M. Blumberg , MD; Betsy Anderson , RN; Nancy White , RN; Susan M. Ray , MD; Jinlene Chan , MSc; William R. Jarvis , MDVol. 21, No. 1 (January 2000) pp. 12-17Stable URL: http://www.jstor.org/stable/10.1086/501690
- Jordi Rello , MD, PhDVol. 20, No. 6 (June 1999) pp. 392-394Stable URL: http://www.jstor.org/stable/10.1086/501638